Methamphetamine Use Disorder Clinical Trial
Official title:
A Novel Drug Combination as a Pharmacotherapeutic for Methamphetamine-Use Disorder
This study will evaluate the behavioral effects of methamphetamine during maintenance on placebo, duloxetine, methylphenidate and duloxetine combined with methylphenidate using sophisticated human laboratory methods.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01982643 -
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT03078075 -
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
|
Phase 3 | |
Terminated |
NCT05711862 -
The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder
|
Phase 2 | |
Recruiting |
NCT05322954 -
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
|
Phase 1 | |
Recruiting |
NCT05760807 -
Intranasal Oxytocin for Methamphetamine Withdrawal in Women
|
N/A | |
Recruiting |
NCT04614584 -
Mirtazapine and Methamphetamine Drug-drug Interaction Study
|
Phase 1 | |
Not yet recruiting |
NCT06320366 -
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
|
N/A | |
Recruiting |
NCT05558358 -
Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06279273 -
A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment
|
N/A | |
Active, not recruiting |
NCT04907357 -
rTMS for Stimulant Use Disorders
|
N/A | |
Completed |
NCT04713124 -
A Telephone-delievered Intervention to Reduce Methamphetamine Use
|
N/A | |
Active, not recruiting |
NCT04791969 -
Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
|
Phase 2 | |
Completed |
NCT00572234 -
Bupropion in the Treatment of Methamphetamine Dependence
|
N/A | |
Terminated |
NCT03106571 -
Study of Pomaglumetad and Methamphetamine
|
Phase 1 | |
Recruiting |
NCT06033365 -
Beginning Early and Assertive Treatment for Methamphetamine Use Disorder
|
N/A |